Prognostic value of lymph node to primary tumor standardized uptake value ratio in unresectable esophageal cancer

[1]  K. Chìn,et al.  A 3-Year Overall Survival Update From a Phase 2 Study of Chemoselection With DCF and Subsequent Conversion Surgery for Locally Advanced Unresectable Esophageal Cancer , 2019, Annals of Surgical Oncology.

[2]  Chi Lin,et al.  Management of Unresectable T4b Esophageal Cancer: Practice Patterns and Outcomes From the National Cancer Data Base , 2019, American journal of clinical oncology.

[3]  G. Ku,et al.  Metabolic assessment by PET in the treatment of esophageal cancer , 2018 .

[4]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[5]  Michael Baumann,et al.  Prognostic Value of Standardized Uptake Ratio in Patients with Trimodality Treatment of Locally Advanced Esophageal Carcinoma , 2018, The Journal of Nuclear Medicine.

[6]  San-Gang Wu,et al.  Patterns of Distant Metastasis Between Histological Types in Esophageal Cancer , 2018, Front. Oncol..

[7]  A. Egashira,et al.  Long-Term Outcome of Definitive Chemoradiotherapy and Induction Chemoradiotherapy Followed by Surgery for T4 Esophageal Cancer with Tracheobronchial Invasion , 2018, Annals of Surgical Oncology.

[8]  C. Hsieh,et al.  Favorable versus unfavorable prognostic groups by post-chemoradiation FDG-PET imaging in node-positive esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy , 2018, European Journal of Nuclear Medicine and Molecular Imaging.

[9]  Y. Doki,et al.  Utility of initial induction chemotherapy with 5-fluorouracil, cisplatin, and docetaxel (DCF) for T4 esophageal cancer: a propensity score-matched analysis. , 2018, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[10]  N. Kadoya,et al.  Whole-body total lesion glycolysis is an independent predictor in patients with esophageal cancer treated with definitive chemoradiotherapy. , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[11]  C. Tseng,et al.  Predictive value of nodal maximum standardized uptake value of pretreatment [18F]fluorodeoxyglucose positron emission tomography imaging in patients with esophageal cancer. , 2017, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[12]  Sungeun Kim,et al.  Ratio of Mediastinal Lymph Node SUV to Primary Tumor SUV in 18F-FDG PET/CT for Nodal Staging in Non-Small-Cell Lung Cancer , 2017, Nuclear Medicine and Molecular Imaging.

[13]  H. Chung,et al.  Prognostic importance of lymph node-to-primary tumor standardized uptake value ratio in invasive squamous cell carcinoma of uterine cervix , 2017, European Journal of Nuclear Medicine and Molecular Imaging.

[14]  T. Deng,et al.  Lipopolysaccharide-induced toll-like receptor 4 signaling in esophageal squamous cell carcinoma promotes tumor proliferation and regulates inflammatory cytokines expression. , 2016, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[15]  Yemi Kim,et al.  Axillary Lymph Node-to-Primary Tumor Standard Uptake Value Ratio on Preoperative 18F-FDG PET/CT: A Prognostic Factor for Invasive Ductal Breast Cancer , 2015, Journal of breast cancer.

[16]  Kazuhiro Yoshida,et al.  Prediction of macrometastasis in axillary lymph nodes of patients with invasive breast cancer and the utility of the SUV lymph node/tumor ratio using FDG-PET/CT , 2015, World Journal of Surgical Oncology.

[17]  F. Lordick,et al.  Value of functional imaging by PET in esophageal cancer. , 2015, Journal of the National Comprehensive Cancer Network : JNCCN.

[18]  J. Ferlay,et al.  Global incidence of oesophageal cancer by histological subtype in 2012 , 2014, Gut.

[19]  T. Borght,et al.  A Systematic Review of the Predictive Value of 18FDG-PET in Esophageal and Esophagogastric Junction Cancer After Neoadjuvant Chemoradiation on the Survival Outcome Stratification , 2014, Journal of Gastrointestinal Surgery.

[20]  V. Rusch,et al.  Successful treatment of esophageal cancer with airway invasion with induction chemotherapy and concurrent chemoradiotherapy. , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[21]  Wolfgang A Weber,et al.  PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial. , 2007, The Lancet. Oncology.

[22]  Harvey Mamon,et al.  FDG-PET/CT Tumor Segmentation-Derived Indices of Metabolic Activity to Assess Response to Neoadjuvant Therapy and Progression-Free Survival in Esophageal Cancer: Correlation With Histopathology Results , 2007, American journal of clinical oncology.

[23]  V. Rusch,et al.  The utility of positron emission tomography in staging of potentially operable carcinoma of the thoracic esophagus: results of the American College of Surgeons Oncology Group Z0060 trial. , 2007, The Journal of thoracic and cardiovascular surgery.

[24]  K. Kaneko,et al.  Definitive chemoradiotherapy for patients with malignant stricture due to T3 or T4 squamous cell carcinoma of the oesophagus , 2003, British Journal of Cancer.

[25]  Y. Nishimura,et al.  Prospective trial of concurrent chemoradiotherapy with protracted infusion of 5-fluorouracil and cisplatin for T4 esophageal cancer with or without fistula. , 2002, International journal of radiation oncology, biology, physics.

[26]  S. Yoshida,et al.  Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  J. Henzen.  Publisher's note , 1979, Brain Research.

[28]  C. Hallemeier,et al.  Utility of 18F‐FDG PET for Predicting Histopathologic Response in Esophageal Carcinoma following Chemoradiation , 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[29]  H. Chung,et al.  Prognostic value of lymph node-to-primary tumor standardized uptake value ratio in endometrioid endometrial carcinoma , 2017, European Journal of Nuclear Medicine and Molecular Imaging.